| Entry |
|
|---|
| Name |
Floxuridine (USP/INN);
FUDR (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C9H11FN2O5
|
|---|
| Exact mass |
246.0652
|
|---|
| Mol weight |
246.1924
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01935 Fluoropyrimidine antineoplastic
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Antiviral, Antimetabolite |
|---|
| Disease |
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07041 | Antineoplastics - antimetabolic agents |
|
|---|
| Other map |
| map00983 | Drug metabolism - other enzymes |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BC Pyrimidine analogues
L01BC09 Floxuridine
D04197 Floxuridine (USP/INN) <US>
USP drug classification [BR:br08302]
Antineoplastics
Antimetabolites
Floxuridine
D04197 Floxuridine (USP/INN)
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01935 Fluoropyrimidine antineoplastic
D04197 Floxuridine
Drug classes [BR:br08332]
Antineoplastic
DG02018 Antimetabolite
D04197 Floxuridine
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Methyltransferases
TYMS
D04197 Floxuridine (USP/INN) <US>
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 17
1 C1y C 20.5100 -17.2900
2 O2x O 19.3900 -16.5200
3 C1x C 20.0900 -18.6200
4 C1y C 18.2700 -17.2900
5 C1y C 18.6900 -18.6200
6 C1b C 17.0100 -16.8700
7 O1a O 17.9200 -19.6700
8 O1a O 16.0300 -17.7800
9 N4y N 21.8400 -16.8000
10 C8x C 21.8400 -15.4000
11 C8y C 23.0300 -17.5000
12 N4x N 24.2900 -16.8000
13 C8y C 24.2900 -15.4000
14 C8y C 23.0300 -14.7000
15 X F 23.0300 -13.3000
16 O5x O 25.4800 -14.7000
17 O5x O 23.0300 -18.9000
BOND 18
1 1 2 1
2 1 3 1
3 2 4 1
4 3 5 1
5 4 6 1 #Up
6 5 7 1 #Down
7 6 8 1
8 4 5 1
9 1 9 1 #Up
10 10 9 1
11 11 12 1
12 12 13 1
13 13 14 1
14 10 14 2
15 14 15 1
16 13 16 2
17 11 17 2
18 11 9 1
|
|---|
